Acutus Medical, Inc.
Acutus Medical, Inc. (AFIB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · AFIB · as of Jun 8, 2026
Key Statistics
Explore Acutus Medical, Inc. Data
afib stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 6 · Buy rate: 16.7%
The AFIB analyst consensus is Hold, based on ratings from 6 Wall Street analysts over the past 3 months. The average 12-month price target is $1.50, representing +749900.00% upside from the current price of $0.00.
Competitors & Peers
afib competitorsAFIB
ARDS
CGHC
EVLO
ICCT
IGNTStock Performance
Full HistoryAbout Acutus Medical, Inc.
Acutus Medical, Inc. is a company dedicated to the treatment of cardiac arrhythmias, focusing on the design, manufacturing, and commercialization of specialized tools for catheter-based ablation proce…
what is acutus medical, inc. · afib stock overview · acutus medical, inc. company profile · who is acutus medical, inc. ceo · afib OTC · acutus medical, inc. headquarters · acutus medical, inc. business segments
About Stock Overview & Key Data
Acutus Medical, Inc. (AFIB) is a Healthcare company in the Medical - Devices industry, listed on OTC since Aug 6, 2020. As of the latest trading session, AFIB stock price is $0.00, with a market capitalization of $5,982. The stock has returned -90.00% over the past 12 months and +0.00% year-to-date.
According to 6 Wall Street analysts, the consensus rating for Acutus Medical, Inc. stock is Hold, with an average 12-month price target of $1.50. In fiscal year 2024, Acutus Medical, Inc. reported revenue of $20.2M and net income of -$9.5M. For detailed data — including Acutus Medical, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Acutus Medical, Inc. (AFIB) stock price is $0.00. The stock is traded on OTC under the ticker symbol AFIB. The 52-week range is $0.00 – $0.01.